期刊文献+

异质性万古霉素中介金黄色葡萄球菌分离率与检测方法评价 被引量:2

Prevalence and detection methods of hetero-resistant vancomycin intermediate Staphylococcus aureus
原文传递
导出
摘要 目的了解医院临床耐甲氧西林金黄色葡萄球菌(MRSA)中异质性万古霉素中介金黄色葡萄球菌(hVISA)的分离率,为寻求一种可用于实验室筛选hVISA简便有效的检测方法。方法收集2014年3月-2015年4月于临床分离的MRSA 205株,分别用16g/L胰酶消化酪蛋白和4μg/ml万古霉素脑心浸液琼脂筛选法(CBHIV4)、宏量E-test法(MET)、E试验法(GRD)及菌群分析曲线(PAP/AUC)法检测hVISA,对比3种检测方法的敏感性及特异性。结果 PAP/AUC、CBHIV4、MET、GRD的4种方法检测hVISA阳性菌株分别为12、18、54、39株;以PAP/AUC作为金标准,CBHIV4、MET、GRD的3种检测方法敏感度分别为80.0%、50.0%、58.3%,特异度分别为96.0%、80.0%、85.7%。结论 16g/L胰酶消化酪蛋白和4μg/ml万古霉素脑心浸液琼脂筛选法有较高的敏感性和特异性,可作为hVISA的初筛方法,代替较为繁琐的菌群分析曲线,并减少E-test纸片的使用,降低检测成本。 OBJECTIVE To research the prevalence of hetero-resistant vancomycin intermediate Staphylococcus aureus(hVISA)among clinical methicillin-resistant Staphylococcus aureus(MRSA)in the hospital and explore a simple and effective method for detecting hVISA.METHODS Totally 205 clinical strains of MRSA were collected from Mar.2014 to Apr.2015.The hVISA isolates were detected by CBHIV4(brain heart infusion agar containing 4μg/ml vancomycin and 16g/L casein),MET(E-test macromethod),GRD(E-test)and PAP/AUC(population analysis profiles/area under the curve).The sensitivity and specificity of CBHIV4 by casein,MET,PAP/AUC and GRD methods were compared.RESULTS The positive strains of hVISA were 12,18,54,39 respectively by the four methods.Taking PAP/AUC method as the gold standard,the sensitivity by CBHIV4,MET and GRD was 80.0%,50.0%,58.3%,and the specificity was 96.0%,80.0%,85.7%respectively.CONCLUSION The CBHIV4 had both high sensitivity and specificity and could be used as the primary screening method of hVISA to reduce the tedious workload of conducting PAP/AUC and the using of E-test and reduce testing costs
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第8期1681-1683,共3页 Chinese Journal of Nosocomiology
基金 山东省医药卫生发展计划基金资助项目(2014WS0310)
关键词 金黄色葡萄球菌 万古霉素 抗药 实验室 技术和方法 Staphylococcus aureus Vancomycin Drug resistance Laboratory Techniques and procedures.
  • 相关文献

参考文献8

  • 1van Hal SJ,Fowler VG Jr.Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections?[J].Clin Infect Dis,2013,56(12):1779-1788.
  • 2许宏涛,陈东科,赖惠英,胡云建,张秀珍.异质性万古霉素中介金黄色葡萄球菌的分离率调查及方法学评价[J].中华医院感染学杂志,2012,22(21):4681-4683. 被引量:5
  • 3刘彩林,陈中举,孙自镛,邱红,柯俊,史莉,张夫红,陈童,邹玖明,龚平,邹晓艳,彭焦武,张才仕,汪玥,欧国平.湖北地区异质性万古霉素中介金黄色葡萄球菌的流行性及检测方法研究[J].中华检验医学杂志,2014,37(1):41-45. 被引量:7
  • 4Satola SW,Farley MM,Anderson KF,et al.Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus,with the population analysis profile method as the reference method[J].J Clin Microbiol,2011,49(1):177-183.
  • 5van Hal SJ,Wehrhahn MC,Barbagiannakos T,et al.Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates[J].J Clin Microbiol,2011,49(4):1489-1494.
  • 6Matsuo M,Cui L,Kim J,et al.Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus(hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu[J].Antimicrob Agents Chemother,2013,57(12):5843-5853.
  • 7Maor Y,Belausov N,Ben-David D,et al.hVISA and MRSA endocarditis:an 8-year experience in a tertiary care centre[J].Clin Microbiol Infect,2014,20(10):730-736.
  • 8Casapao AM,Leonard SN,Davis SL,et al.Clinical outcomes in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus(hVISA)bloodstream infection[J].Antimicrob Agents Chemother,2013,57(9):4252-4259.

二级参考文献27

  • 1代洪,范学工.金黄色葡萄球菌对万古霉素耐药情况调查[J].临床检验杂志,2005,23(4):259-262. 被引量:14
  • 2Sarah W, Monica M, Karen F, et el. Comparison of Detec- tion Methods for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus, with the Population Analysis Profile Method as the Reference Method[J]. J Clan Mierobiol,2011, 49(1) : 177-183.
  • 3Sun W, Chen H, Liu Y, et al. Prevalence and characteriza- tion of He terogeneous vancomyc-Intermediate Stapylococcus aureus isolates from 14 cities in China[J]. Antimicrob Agents Chemother, 2009,53(9) : 3642-3649.
  • 4Fitzgibbon MM, Rossney AS, O Connell B. Investigation o3 reduced susceptibility to glycopeptides among methicillin-re- sistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of bet erogeneously glyeopeptide-intermediate S. aureus[J ]. J Clin Microbiol,2007,45(10) :3263 -3269.
  • 5Otter JA, French GL. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of heahhcare-associated infection [ J]. J Hosp Infect, 2011, 79 : 189-193.
  • 6Kock R, Becker K, Cookson B, et al. Methicillin-resistant Staphylococcus aureus ( MRSA ) : burden of disease and control challenges in Europe[ J]. Euro Surveill, 2010, 15:19688.
  • 7Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resistant Staphylococcu.- aureus clinical strain with reduced vancomycin susceptibility[ J ] . J Antimierob Chemother. 1997.40:135-136.
  • 8Brown DF, Edwards DI, Hawkey PM, et al. Guidelines for the laboratory diagnosis and susceptibility testing of methicillin- resistant Staphylococcus aureus ( MRSA ) [J]. J Antimicrob Chemother, 2005, 56 : 1000-1018.
  • 9Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Second Informational Supplement. M100-S22. Wayne, PA : CLSI,2011.
  • 10Wootton M, Howe RA, Hillman R, et al. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital [ J ]. J Antimicrob Chemother, 2001,47:399-403.

共引文献7

同被引文献10

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部